Contact
 

History of the Scientific Strategic Plan

The Global HIV Vaccine Enterprise emerged from a consensus paper signed by two-dozen researchers, funders and advocates published in the journal Science.  Two years later, the Enterprise's Scientific Strategic Plan for accelerating HIV vaccine research was published in the February 2005 issue of Public Library of Science (PLoS) — Medicine. The plan described the major challenges facing the field and made recommendations in six priority areas as noted below.

The 2005 Plan catalyzed major, new activities and funding commitments of a number of government and non-government organizations. It also led to the creation of new research structures and new ways of collaborating on a global scale.

1
Vaccine Discovery

The immediate goal is to design candidate vaccines that cause the immune system to produce protective responses from both of its major arms — cellular immunity and neutralizing antibodies.

Read More...

2
Laboratory Standardization

The laboratory assays that researchers use to assess immune response may not be comparable, severely hampering decisions about which candidates to pursue for further testing.

Read More...

3
Product Development and Manufacturing

Once researchers have identified a vaccine design that they believe is promising, a critical phase of vaccine research is developing a manufacturing process that yields consistent batches over time.

Read More...

4
Clinical Trials Capacity

Three phases of clinical trials in humans are required to fully test a vaccine candidate.

Read More...

5
Regulatory Issues

National regulatory oversight of clinical trials is the cornerstone of safe and scientifically valid medical research.

Read More...

6
Intellectual Property Issues

Researchers routinely seek patents and other intellectual property protections for their inventions.

Read More...

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account